SEC Form 4 research
| Issuer | ORAMED PHARMACEUTICALS INC. |
|---|---|
| Tickers | ISTG, ORMP.OB, ORMP |
| Reporting owners | 32 |
| Officers and directors | 13 |
| Last public filing | 2026-10-02 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-02 | 2026-10-01 | Gabay Avraham | S | 20,000 | $4.51 | Not reported |
| 2026-10-02 | 2026-10-01 | Hexter Joshua | S | 30,000 | $4.51 | Not reported |
| 2026-09-25 | 2026-09-24 | KIDRON NADAV | A | 368,765 | Not reported | Not reported |
| 2026-09-25 | 2026-09-24 | KIDRON NADAV | A | 349,497 | Not reported | Not reported |
| 2026-09-25 | 2026-09-24 | Hexter Joshua | A | 209,291 | Not reported | Not reported |
| 2026-09-25 | 2026-09-24 | Hexter Joshua | A | 75,455 | Not reported | Not reported |
| 2026-09-25 | 2026-09-24 | Kidron Miriam | A | 209,291 | Not reported | Not reported |
| 2026-09-25 | 2026-09-24 | Kidron Miriam | A | 208,125 | Not reported | Not reported |
| 2026-09-25 | 2026-09-24 | Gabay Avraham | A | 209,291 | Not reported | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.